Purpose: The aim of the study was to assess the presence and spectrum of cardiac abnormalities identified by cardiac magnetic resonance (CMR) in women with hypereosinophilic syndrome (HES) of undefined etiology, who present with normal electrocardiography (ECG) and transthoracic echocardiography (TTE) and no history of heart disease.
Introduction
Hypereosinophilic syndrome (HES) encompasses the spectrum of diseases characterized by increased blood eosinophils and tissue damage.
1,2 Although both myeloproliferative and lymphocytic variants of HES have been identified, most subjects with HES still fall into the undefined complex category with organ involvement and unknown mechanism of hypereosinophilia. [1] [2] [3] HES frequently involves the heart, and the spectrum of cardiac abnormalities includes myocarditis, intracardiac thrombi, myocardial ischemia, valvular heart disease, pericarditis, and/or rhythm disorders. 4, 5 Indeed, heart involvement is the major cause of morbidity and mortality in patients with HES. Interestingly, women are less frequently affected and have better clin-ical outcomes than men. 1, 6, 7 Clinically, electrocardiography (ECG) and transthoracic echocardiography (TTE) are the most often used screening tools for detection and monitoring of cardiac involvement. Recent case reports suggest that cardiac magnetic resonance (CMR) may yield incremental diagnostic benefit by providing more comprehensive assessment of cardiac function and structure. 8 -11 To date, there is a paucity of data regarding the utility of CMR in the detection of cardiac abnormalities in subjects with HES, normal ECG and TTE, and no history of heart disease. Furthermore, cardiac involvement among women with HES of undefined etiology has not been adequately elucidated. Therefore, the aim of the study was to assess the presence and spectrum of cardiac abnormalities identified by standard CMR in women with HES of undefined etiology, who present with normal ECG and TTE and no history of heart disease.
Methods

Study population
Ten consecutive women with HES of unknown etiology were enrolled in the study. Exclusion criteria included: a) eosinophilia of known cause; b) myeloproliferative and lymphocytic HES variant; c) history of heart disease; d) abnormal ECG (presence of pathologic Q wave, ST segment abnormalities, and/or rhythm disorders); e) abnormal TTE (left ventricular [LV] ejection fraction [EF] < 50%, segmental wall motion abnormality, moderate/severe valve regurgitation/stenosis, endomyocardial thickening, intracardiac thrombus, and/or pericardial effusion); f ) renal insufficiency (creatinine clearance < 60 mL/kg/min); and f ) contraindication to CMR including magnetic resonance incompatible implants or electronic devices, inability to perform breath hold, and claustrophobia. At enrollment all subjects were scheduled for CMR and subsequently followed for the onset of heart failure. At follow-up, standard TTE was performed. The study was approved by institutional ethics committee and informed consent was obtained from each patient.
CMR imaging protocol
Breath-hold, ECG-gated CMR was performed on a 1.5-tesla scanner (Magnetom Sonata Maestro Class, Siemens, Erlangen, Germany) equipped with multichannel cardiac phased array coil. Cine imaging was performed in LV 2-, 3-, and 4-chamber apical views as well as in short-axis views encompassing the entire LV and right ventricular (RV) myocardium using balanced steady-state free precession (SSFP) gradient echo (slice/gap thickness, 10/0 mm; matrix, 256 © 192; in-plane resolution, 1.4 © 1.4 mm 2 ; repetition time (TR)/echo time (TE), 3.0/ 1.3 ms; flip angle, 59°; parallel imaging technique (generalized autocalibrating partially parallel acquisition [GRAPPA]). Morphologic images were acquired with T 2 -weighted short tau inversion recovery (STIR) (slice/gap thickness, 10/0 mm; matrix, 256 © 192; in-plane resolution, 1.4 © 1.4 mm 2 ; TR, 2 to 3 RR depending upon the RR interval; TE, 65 ms; flip angle, 180°; GRAPPA) and T 1 -weighted turbo spin echo (TSE) imaging (slice/gap thickness, 10/0 mm; matrix, 256 © 192; in-plane resolution, 1.4 © 1.4 mm 2 ; TR, 2 to 3 RR depending upon the RR interval; TE, 6.9 ms; flip angle, 180°) in short axis and axial views. STIR images were acquired with surface coil correction intensity algorithms, whereas T 1 -weighted imaging was obtained with body coil alone. T 1 -weighted imaging was performed before and early after intravenous infusion of 0.1 mmol/kg body weight of gadobutrol (Gadovist, Bayer Schering Pharma, Berlin, Germany). Ten minutes after contrast injection, late gadoliniumenhancement (LGE) imaging was performed using T 1 -weighted segmented inversion-recovery pulse sequence (slice/gap thickness, 10/0 mm; matrix, 256 © 192; in-plane resolution, 1.4 © 1.4 mm 2 ; TR/TE, 650/4.9 ms; flip angle, 30°; inversion time set to null normal myocardium).
CMR image analysis
An independent observer with 10 years of experience in CMR, who was blinded to clinical data, assessed cine, T 1 -weighted pre-and post-contrast, T 2 -weighted STIR, and LGE images off-line (MASS Medis, Leiden, The Netherlands) using 17 LV and 9 RV segment models.
On cine images, as previously described, endocardial and epicardial RV and LV borders were outlined on short-axis images to calculate the EF as well as end-diastolic volume (EDV), end-systolic volume (ESV), and myocardial mass, which were indexed to the surface area of the body. 12 On T 1 -weighted and STIR images, mean T 2 and T 1 signal intensity (SI) (pre-and post-contrast) were measured by quantitative analysis in a) individual LV segments, b) the entire LV myocardium in axial views, and c) skeletal muscle (erector spinae/lattisimus dorsi) in the same slice. 13 T 2 myocardial SI was related to skeletal muscle SI and the ratio of T 2 -SI was calculated. The ratio of myocardial early gadolinium enhancement (EGE) was calculated as the ratio of myocardial enhancement to skeletal muscle enhancement. Global (i.e., determined in the entire LV myocardium in an axial view) ratios of T 2 -SI ² 2.0 and EGE ² 4.0 were considered abnormal, with the first indicating myocardial edema and the second indicating myocardial hyperemia/hyperpermeability of capillaries. 13 By analogy, T 2 -SI ratio ² 2.0 and EGE ratio ² 4.0 were considered abnormal for individual LV segments. 11, 14 LGE images were assessed qualitatively for the presence and location of hyperintense lesions in contrast to hypointense normal myocardium.
LGE lesions in the LV myocardium were defined as subendocardial (adjacent to the endocardium but not the epicardium), midwall (not adjacent to the endocardium and the epicardium), subepicardial (adjacent to the epicardium but not the endocardium), and transmural (adjacent to the endocardium and the epicardium). Based on visual assessment of distribution, LGE lesions were classified as nonischemic or ischemic.
LGE size was assessed manually by planimetry on short-axis slices, with delineation of areas of hyperenhancement. The volume of LGE lesions was calculated, and their extent (LGE index) was expressed as the percentage of myocardial volume.
According to Lake Louise Criteria, CMR was considered to indicate myocardial inflammation in the presence of two or more of: a) increase in regional or global T 2 -SI ² 2.0; b) global EGE ratio ² 4.0; and c) one or more focal nonischemic LGE lesion (s). 13 
TTE
TTE was performed using the Vivid 7 ultrasound system (GE Vingmed Ultrasound A/S, Horten, Norway). The LVEF was calculated using the modified biplane Simpson's method. LV diastolic function was evaluated in accordance with the guidelines of the American Society of Echocardiography, as previously described.
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Statistical analysis
Statistics was performed using SPSS software (version 12.0, SPSS Inc., Chicago, IL, USA), with P < 0.05 considered statistically significant. Categorical data were presented as numbers (percentages) and continuous data, as mean « standard deviation. The normal distribution was verified using Kolmogorov-Smirnov test. Independent and dependent categorical variables were compared by Fisher's exact and Cochran's Q tests, and continuous variables by unpaired or paired Student t-test. The relationship between the extent/volume of LVLGE and inflammatory markers was assessed using Pearson product-moment correlation.
Results
Study group
Ten women with HES (mean age 48 « 14 years) were enrolled in the study (Table 1) . No patient demonstrated heart failure, angina symptoms, or history of perimyocarditis or intracardiac thrombus. Three patients reported cigarette smoking, 4 had hypertension, 3, hypercholesterolemia, 1, obesity (body mass index ² 30 kg/m 2 ), and 1, diabetes mellitus. At enrollment (i.e., when CMR was performed), white blood cell counts were 9692 « 5854 cells/µL, blood eosinophil counts, 565 « 520 cells/ µL, and serum C-reactive protein levels, 13.2 « 11.5 mg/L. Six subjects demonstrated abnormal C-reactive protein (>5 mg/dL). At enrollment the mean disease duration since diagnosis was 3.3 « 4.0 years. At diagnosis, white blood cell count was 16690 « 10709 cells/µL, blood eosinophil count, 7744 « 5990 cells/µL, and serum C-reactive protein, 35.8 « 15.7 mg/L. These represented the maximum measured values since diagnosis. At diagnosis, glucocorticoids were introduced in all subjects with a dose of 1 mg/kg/day of prednisone or its equivalent that was subsequently adjusted to the lowest possible dose to maintain eosinophil counts and control clinical manifestation. To control disease at the time of enrollment, 4 patients received high daily doses of glucocorticoids, ranging from 20 to 40 mg of prednisone or its equivalent, and 1 received combined glucocorticoid and hydoxyurea therapy due to side-effects of glucocorticoids. The remaining 5 patients required low daily doses of glucocorticoids equal to¯10 mg of prednisone or its equivalent. One patient was on beta-blockers, 3 on angiotensin-converting enzyme inhibitors, 2 on diuretics, and 2 on calcium blockers.
Cardiac magnetic resonance
The LVEF was 68.5 « 5.7%, RVEF, 62.2 « 7.6%, LVEDV index, 62.7 « 14.7 mL/m 2 , and RVEDV index, 64.6 « 11.1 mL/m 2 ( Table 2) . Regional LV and RV function as well as EDV were normal in all subjects. CMR revealed cardiac abnormalities in 6 patients. Nonischemic LGE lesions were found within the LV myocardium in 5 subjects in 4.0 « 0.7 LV segments (Fig. 1) . No LGE lesion was classified as ischemic. Three subjects presented with more than 2 separate LGE lesions. LVLGE lesions were subendocardial in 3 patients, midwall in 4, subepicardial in 4, and transmural in 2 (P = 0.30). The volume of LVLGE was 1.9 « 2.2 mL, and the LVLGE index There were no differences between both groups in actually measured blood eosinophil count (739 « 578 versus 391 « 447 cells/µL, P = 0.32), white blood cell count (10302 « 7226 versus 9082 « 4895 cells/µL, P = 0.76), and C-reactive protein (16.6 « 13.9 versus 9.8 « 8.8 mg/L, P = 0.38). LVLGE volume and LVLGE index correlated with maximum measured blood eosinophil count (r = 0.80, P = 0.006, and r = 0.77, P = 0.009, respectively), but not with maximum C-reactive protein levels, white blood cell count, or disease duration since diagnosis (all P = NS).
According to Lake Louise Criteria, 3 patients demonstrated evidence of myocardial inflammation (Fig. 2) . All 3 patients demonstrated increased myocardial T 2 -SI ratio and EGE ratio; two had nonischemic LGE lesions, and the third did not. In those 3 subjects T 2 -SI ratio ² 2.0 was present in 6.3 « 0.6 LV segments and an EGE ratio ² 4.0 in 5.7 « 0.6 LV segments. Actually measured blood eosinophil count in patients with and without evidence of myocarditis was 1058 « 520 cells/µL and 354 « 377 cells/µL (P = 0.04), respectively. Two patients had abnormal localized pericardial thickening, and 3 had pericardial effusion.
Follow-up
During 14.1 « 1.8 months of follow-up after enrollment, no patient demonstrated disease relapse or Continuous data are presented as mean « standard deviation with range in brackets. *P < 0.05 for comparison between subjects with and without late gadolinium enhancement in the myocardium †P < 0.05 for comparison with actually measured respective parameters Continuous data are presented as mean « standard deviation with range in brackets. *P < 0.05 for comparison between subjects with and without late gadolinium enhancement lesions in the myocardium Fig. 1 . Subendocardial (A) and epicardial (B) late gadolinium enhancement lesions (arrows) in subjects with hypereosinophilic syndrome.
symptoms of heart failure. At follow-up, the LVEF was 68.1 « 4.4% and no subject had LVEF<50%. Three subjects showed LV diastolic dysfunction, all of whom presented LVLGE in CMR. The LVEF at enrollment (68.5 « 5.7%) and follow-up (67.8 « 4.0%) did not differ (P = 0.61).
Discussion
The current study demonstrates the first systematic evaluation of CMR evidence of heart involvement in HES. Despite the absence of abnormalities by ECG and TTE and no history of heart disease CMR frequently identified cardiac abnormalities in women with HES of unknown etiology. Most subjects demonstrated LGE lesions that were distributed in all LV myocardial layers and did not produce regional wall motion abnormalities. Importantly, the extent of LGE lesions was directly related to the maximum measured blood eosinophil count, a finding supporting the link between eosinophilia and myocardial damage. Despite clinically and laboratory controlled disease, CMR evidence of myocarditis was not uncommon and was associated with higher blood eosinophil count.
Both myocardial damage and cardiomyocyte loss in HES have been linked to eosinophilic myocarditis, which occurs in up to 60% of subjects. [17] [18] [19] Prior studies have evaluated cardiac involvement without regard to HES variants, and the prevalence of cardiac abnormalities in subjects with HES of unknown etiology has not been established. 20 -23 Cardiac disease in HES appears to progress through 3 stages; acute myocardial necrosis (early necrotic stage) is followed by thrombus formation (thrombo-necrotic stage) and ultimately progresses to endomyocardial fibrosis that results in restrictive cardiomiopathy. 5 Initial case reports using CMR have documented the wide spectrum of cardiac abnormalities in HES. 8 -10,23-30 Accordingly, CMR allows detection of heart involvement in all stages, including signs of myocardial necrosis, fibrosis, myocarditis, intracardiac thrombi, and pericardial effusion. The current study shows that despite normal ECG and TTE, women with HES often demonstrate cardiac abnormalities, the most common of which are LGE lesions distributed throughout all myocardial layers. This observation may be valuable because cardiac involvement in HES represents the major cause of deaths, despite the belief that prognosis is better in women than men with HES. 1, 6, 7 However, the impact of sex on the presence and extent of cardiac abnormalities depicted in CMR is unknown.
In the current study, CMR-demonstrable cardiac involvement appears to represent an early stage of heart disease in HES. This speculation may be based on several facts. First, the early stage is usually asymptomatic, and none of our subjects had a history of heart disease. Second, LGE lesions were not extensive nor accompanied by interventricular thrombi, which are encountered at the second stage of HES cardiac disease. 5, 23, 26, 27, 30, 31 Third, no subject had extensive subendocardial fibrosis, which occurs at the final stage of HES heart disease. 5, 25 The myocardial abnormalities in the current study may represent both necrotic and fibrotic lesions. Most of the LGE areas were not accompanied by CMR signs of myocarditis and likely reflected residual irreversible myocardial fibrosis following a healed inflammatory process. 5 Nevertheless, the resolution of LGE lesions cannot be ruled out in subjects with signs of myocarditis on CMR. 31, 32 In the current study, LGE lesions represented predominantly nonischemic myocardial damage; obvi- ously, we could not unequivocally exclude their ischemic origin if they involved the subendocardium. 33 The volume and extent of LGE lesions were directly associated with the maximum level of blood eosinophil count at disease diagnosis. These findings support the link between eosinophil level and myocardial damage, which has been documented in endomyocardial biopsy samples. 18, 34 Interestingly, Salemi and associates 35 demonstrated a relationship between the volume of LGE and mortality in subjects with endomyocardial fibrosis. However, the prognostic value of LGE lesions in the early stage of heart disease in HES remains to be determined. It seems crucial, if LGE lesions coexist with signs of active myocardial disease. In fact, different scenarios have been reported in the course of active myocarditis in HES including the complete resolution of myocarditis and persistence of LGE lesions in the myocardium. 10, 28, 36 In addition, both scenarios were also observed in other types of myocardial inflammation, including vasculitis and viral etiology, and were linked to prognosis. 31, 32 Prior case reports documented the ability of CMR to depict eosinophilic myocarditis in HES confirmed by endomyocardial biopsy. 9, 25, 28 In the current study, despite the apparent clinical and laboratory control of disease, 3 women demonstrated CMR evidence of myocarditis. Of note, CMR abnormalities were associated with higher levels of blood eosinophil count, that reflects the role of eosinophils in myocardial inflammation. Importantly, the association may suggest the need for further decrease in blood eosinophil count in those subjects. However, more studies are needed to clarify the issue.
Several study limitations has to be acknowledged. First, the study population was small, and the results should be confirmed in a larger patient cohort. Second, patients with low creatinine clearance were excluded because of the relative contraindication to gadolinium contrast, and the results may not be applicable to a broader population of patients with HES. Third, endomyocardial biopsy was not performed to confirm cardiac involvement in studied subjects. Fourth, we did not use T 1 and T 2 mapping sequences, which are more sensitive than STIR for myocardial edema imaging. Finally measurements of signal intensity for myocarditis detection might be affected by parallel imaging and a multichannel coil.
37,38
Conclusions
Despite normal ECG and TTE and no history of heart disease, women with HES of unknown etiology frequently demonstrate cardiac abnormalities by CMR, including nonischemic LGE lesions and signs of myocarditis, that are associated with blood eosinophilia.
